Expression of multiple forms of clusterin during light-induced retinal degeneration.
OBJECTIVE
Clusterin has been associated with active cell death in several different model systems, including animal models of retinal degeneration. Clusterin is also expressed in normal tissues, a finding that leads to the question of how it could then play a cell death-specific role during tissue regression. To address this paradox, we have examined clusterin expression during light-induced retinal damage in rats.


METHODS
Normal albino rats were reared in darkness and then exposed to intense visible light to induce retinal degeneration. Clusterin expression was then examined at various times after light treatment. Standard molecular techniques including Northern analysis, immunohistochemistry, and Western analysis were employed.


RESULTS
Northern analysis established that the largest increase in clusterin expression occurs after a decrease in interphotoreceptor retinoid binding protein, IRBP, expression (an indication of a photoreceptor cell dysfunction) and after an increase in heme oxygenase 1, HO-1, expression (an oxidative stress inducible gene), suggesting that induction of clusterin expression is an oxidative stress response. Immuno-histochemical analysis with two different clusterin-specific antibodies, anti(SGP-2) and anti(301), localized distinct forms of clusterin to Müller cells and degenerating photo-receptor cells. Western analysis demonstrated degeneration associated isoforms of clusterin in light treated retina that are not present in normal retina.


CONCLUSIONS
Clusterin over-expression is characteristic of a retinal degeneration phenotype and we propose that clusterin action may be defined by the nature in which it is modified. We hypothesize that alternate processing leads to retinal degeneration-specific forms of the protein (65, 61, and 50 kDa) that are not present in normal retina.
Wong
P
P
Department of Biological Sciences, University of Alberta, Edmonton, Canada. pwwong@ualberta.ca
Ulyanova
T
T
Organisciak
D T
DT
Bennett
S
S
Lakins
J
J
Arnold
J M
JM
Kutty
R K
RK
Tenniswood
M
M
vanVeen
T
T
Darrow
R M
RM
Chader
G
G
D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D051152:Clusterin; D003623:Dark Adaptation; D005136:Eye Proteins / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism*; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism; D051547:Heme Oxygenase-1; D007124:Immunoenzyme Techniques; D008027:Light; D008297:Male; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism*; D020033:Protein Isoforms / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011833:Radiation Injuries, Experimental / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000528:radiation effects*; D012162:Retinal Degeneration / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D012177:Retinol-Binding Proteins / Q000378:metabolism; D000099214:Retinol-Binding Proteins, Interstitial
D051152:Clusterin; D005136:Eye Proteins; D006023:Glycoproteins; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; D018832:Molecular Chaperones; D020033:Protein Isoforms; D012333:RNA, Messenger; D012177:Retinol-Binding Proteins; D000099214:Retinol-Binding Proteins, Interstitial